drugset / Trial / NCT06807619

A Study of Sotorasib in People With Brain Tumors

NCT06807619

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The researchers are doing this study to find out how effective sotorasib is at getting into KRAS G12C+ brain tumors. The researchers will also find out whether sotorasib is a safe and effective treatment for people undergoing surgical resection of KRAS G12C+ metastatic brain tumors, and do tests that show how the body absorbs, distributes, and gets rid of sotorasib.

Timeline

Start
2025-01-29
Primary completion
2028-01
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sotorasib Small molecule

Indications